Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05122832
Other study ID # 1197
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 23, 2021
Est. completion date August 20, 2022

Study information

Verified date March 2023
Source Asfendiyarov Kazakh National Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a cross-sectional study that aims to study the prevalence of risk factors of noncommunicable diseases in people aged 18 to 69 years using the standardized and adopted STEPS questionnaire in the Republic of Kazakhstan.


Description:

The WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) is a simple, standardized method for collecting, analysing and disseminating data on key NCD risk factors in countries. The survey instrument covers key behavioral risk factors: tobacco use, alcohol consumption, physical activity, unhealthy diet, as well as key biological risk factors: overweight and obesity, raised blood pressure, raised blood glucose, and abnormal blood lipids.


Recruitment information / eligibility

Status Completed
Enrollment 20400
Est. completion date August 20, 2022
Est. primary completion date August 20, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years to 69 Years
Eligibility Inclusion Criteria: - Age Limits 18-69 years

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Blood test
Glucose Glycosylated hemoglobin Triglycerides Total cholesterol HDL Cholesterol LDL Cholesterol Creatinine COVID-19 Antibody IgM to N protein SARS-Cov-2 (Abbott) COVID-19 Antibody IgG to N protein SARS-Cov-2 (Abbott)
STEPwise Approach to NCD Risk Factor Surveillance (STEPS)
The WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) is a simple, standardized method for collecting, analysing and disseminating data on key NCD risk factors in countries. The survey instrument covers key behavioral risk factors: tobacco use, alcohol consumption, physical activity, unhealthy diet, as well as key biological risk factors: overweight and obesity, raised blood pressure, raised blood glucose, and abnormal blood lipids. Through the use of expanded modules, the survey instrument can be expanded to cover a range of topics beyond these risk factors, such as oral health, sexual health and road safety.
Spirometry
Spirometry is a common office test used to assess how well your lungs work by measuring how much air you inhale, how much you exhale and how quickly you exhale.

Locations

Country Name City State
Kazakhstan Kazakhstan Almaty

Sponsors (1)

Lead Sponsor Collaborator
Asfendiyarov Kazakh National Medical University

Country where clinical trial is conducted

Kazakhstan, 

Outcome

Type Measure Description Time frame Safety issue
Primary tobacco use currently smoke tobacco, currently smoke tobacco daily, age started smoking, daily smokers smoking manufactured cigarettes 1 year
Primary alcohol consumption lifetime abstainers, past 12 month abstainers, currently drink (drank alcohol in the past 30 days), heavy episodic drinking (6 or more drinks on any occasion in the past 30 days). 1 year
Primary physical activity insufficient physical activity (defined as < 150 minutes of moderate-intensity activity per week, or equivalent), physical activity on average per day (minutes), not engaging in vigorous activity. 1 year
Primary unhealthy diet days fruit consumed in a typical week, servings of fruit consumed on average per day, days vegetables consumed in a typical week, servings of vegetables consumed on average per day, less than 5 servings of fruit and/or vegetables on average per day, always or often add salt or salty sauce to their food before eating or as they are eating, always or often eat processed foods high in salt. 1 year
Primary BMI overweight (BMI = 25 kg/m2), obese (BMI = 30 kg/m2), normal weight 1 year
Primary raised blood pressure systolic blood pressure - SBP (mmHg), including those currently on medication for raised BP, diastolic blood pressure - DBP (mmHg), including those currently on medication for raised BP, raised BP (SBP = 140 and/or DBP = 90 mmHg or currently on medication for raised BP), raised BP (SBP = 140 and/or DBP = 90 mmHg or currently on medication for raised BP) who are not currently on medication for raised BP. 1 year
Primary raised blood glucose fasting blood glucose, including those currently on medication for raised blood glucose, impaired fasting glycaemia (plasma venous value =6.1 mmol/L (110 mg/dl) and <7.0 mmol/L (126 mg/dl)), raised fasting blood glucose (plasma venous value = 7.0 mmol/L (126 mg/dl)) or currently on medication for raised blood glucose. 1 year
Primary abnormal blood lipids total blood cholesterol, including those currently on medication for raised cholesterol, raised total cholesterol, 1 year
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06294964 - Intervention and Effect of Sleep Pattern on Cardio-cerebrovascular Disease N/A
Recruiting NCT04447144 - Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome
Recruiting NCT06312072 - Understanding Risk Factors for Progressive Chronic Kidney Disease in Malawi
Not yet recruiting NCT06224556 - A Personalized Prevention Program (PPP) Based on the Comprehensive Geriatric Assessment (CGA) for the Prevention of Multidimensional Frailty Related to Non-communicable Chronic Diseases (NCDs) in Older People N/A
Recruiting NCT04947787 - Establishing a Physical Activity Referral Scheme for People With Noncommunicable Diseases in the German Healthcare System N/A
Not yet recruiting NCT05450406 - The Inland Norway Healthy Life Center Study N/A